The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
Open accessAbstract
Evidence of reduced blood-brain barrier (BBB) integrity preceding other Alzheimer's disease (AD) pathology provides a strong link between cerebrovascular angiopathy and AD. However, the "Vascular hypothesis", holds that BBB leakiness in AD is likely due to hypoxia and neuroinflammation leading to vascular deterioration and apoptosis. We propose an alternative hypothesis: amyloidogenesis promotes extensive neoangiogenesis leading to increased vascular permeability and subsequent hypervascularization in AD. Cerebrovascular integrity was characterized in Tg2576 AD model mice that overexpress the human amyloid precursor protein (APP) containing the double missense mutations, APPsw, found in a Swedish family, that causes early-onset AD. The expression of tight junction (TJ) proteins, occludin and ZO-1, were examined in conjunction with markers of apoptosis and angiogenesis. In aged Tg2576 AD mice, a significant increase in the incidence of disrupted TJs, compared to age matched wild-type littermates and young mice of both genotypes, was directly linked to an increased microvascular density but not apoptosis, which strongly supports amyloidogenic triggered hypervascularity as the basis for BBB disruption. Hypervascularity in human patients was corroborated in a comparison of postmortem brain tissues from AD and controls. Our results demonstrate that amylodogenesis mediates BBB disruption and leakiness through promoting neoangiogenesis and hypervascularity, resulting in the redistribution of TJs that maintain the barrier and thus, provides a new paradigm for integrating vascular remodeling with the pathophysiology observed in AD. Thus the extensive angiogenesis identified in AD brain, exhibits parallels to the neovascularity evident in the pathophysiology of other diseases such as age-related macular degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inflammation affects the BBB,126”
From Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging (2013) · cites this paper as [126]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“we were unable to demonstrate a decrease in claudin‐5 in AD, as previously reported [127]”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection (2023) · cites this paper as [127]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“Another potential mediator of cerebrovascular disruption in AD is a highly toxic dodecameric 56 kDa abeta oligomer, referred to as “abeta*56” that has been directly implicated in memory loss in Tg2576 mice”
BackgroundRetractedCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627 · cited 1×
“Areas within the brain section containing high density (‘‘hotspots’’) [39] CD105 staining were imaged using the 206/0.”
MethodStructure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · cited 1×
“The physical seal of the BBB is maintained by several different interendothelial tight junctional complexes (reviewed by [31,32]) comprised of a variety of plasma membrane spanning proteins (like occludin), scaffold cytoplasmic proteins (like ZO-1) and the actin cytoskeleton.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 2×
“These mice express human APP695 containing the Swedish missense mutations (K670N/M671L) or APPsw [33], under control of the hamster prion protein promoter (Taconic).”
BackgroundMethodDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · cited 1×
“However, recent studies have found that vascular risk factors and neurovascular dysfunction associated with hypotension, hypertension [6,7], cholesterol levels, type II diabetes mellitus [8], smoking [9] and oxidative stress [10] play integral roles in the pathogenesis of AD [11].”
BackgroundRAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611 · cited 2×
“dysfunction leads to neurodegenerative changes including accumulation of Ab [27,28], neuroinflammation [29] and ensuing”
BackgroundResultBell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Research works printed but not linked: 1
- MM Verbeek, 1997, The role of amyloid in the pathogenesis of Alzheimer's disease., Biol Chem, 378, 937
Cited by
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672
“…of exogenous tracers 4 and 10 mo Cortex Ujiie et al., 2003 Loss of BBB tight junctionsa,d 18 and 24 mo; not studied before 18 mo Cortex, hippocampus Biron et al., 2011 Loss of LRP1 endothelial expression 4 and 6 mo Cortex, hippocampus, thalamus Deane et al., 2004 Increased RAGE vascular…”
BackgroundThe vascular basement membrane in the healthy and pathological brain
Thomsen, M. S., Routhe, L. J., & Moos, T. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17722436 · Cited by 490
“This would gradually lead to vessel wall rigidity and reduced cerebral blood flow, hence creating the basis for accumulation of Ab and subsequent CAA and capillary sprouting.(115,145) The reduced cerebral blood flowwas further correlated to the accumulation of Ab in the AD brain.”
BackgroundKent, S. A., Spires-Jones, T. L., & Durrant, C. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02196-w · Cited by 446
Neurological Diseases in Relation to the Blood–Brain Barrier
Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 445
“In a study in transgenic mice with genes for the familial form of Alzheimer’s disease, amylodogenesis was found to mediate BBB disruption and leakiness through promoting neoangiogenesis and hypervascularity by causing a redistribution of tight junction proteins (Figure 6) (Biron et al, 2011).”
Background
Metadata
- Authors
- Biron, K. E., Dickstein, D. L., Gopaul, R., & Jefferies, W. A.
- Affiliations
- University of British Columbia (CA)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Biron, Kaan E.
- Dickstein, Dara L.
- Gopaul, Rayshad
- Jefferies, Wilfred A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-31
- Volume
- 6
- Issue
- 8
- Pages
- e23789
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3166122
- OpenAlex
- W2063038783
- Cited by
- 300
- References
- 73
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 18 · 2023: 18 · 2022: 25 · 2021: 31 · 2020: 29 · 2019: 11 · 2018: 17 · 2017: 14 · 2016: 20 · 2015: 20 · 2014: 26 · 2013: 22 · 2012: 14
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, amyloidogenesis, cerebral angiogenesis, blood-brain barrier permeability, hypervascularity, tight junctions, occludin, ZO-1, cerebrovascular integrity, vascular remodeling, neovascularization
- MeSH terms
- Aging, Alzheimer Disease, Amyloid, Animals, Blood-Brain Barrier, Brain, Female, Humans, Male, Mice, Transgenic, Neovascularization, Pathologic, Permeability, Signal Transduction, Apoptosis, Tight Junctions, Mice, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease. https://app.cochat.ai/papers/10.1371/journal.pone.0023789
- The paper
- Biron, K. E., Dickstein, D. L., Gopaul, R., & Jefferies, W. A. (2011). Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0023789
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.